Chicago, IL, July 24, 2014 --(PR.com
)-- For the first time ever, Q1 Productions is hosting the Pharmaceutical and Medical Device Scientific Communications Conference, offering tailor-made, high-level presentations and open floor discussions to scientific communications professionals.
Attendees to the conference will have the opportunity to network and share ideas with fellow scientific communications professionals, hear case studies from leading pharmaceutical and medical device companies, and participate in interactive panel discussions that address the most top-of-mind issues in the industry. More than a dozen scientific communications experts will be leading in-depth presentations and panel discussions, including Ryan Dammerman of Therakos, Inc., John Smith of Novo Nordisk, and Kim Pepitone of Cactus Communications and ISMPP.
Unique to this conference is an open floor panel discussion led by editors and publishers of medical journals, who will provide a first-hand perspective on the submissions they receive from scientific communications professionals. Nancy Berliner of Blood Journal, Neil Adams of Nature Publishing Group, and Sherwood Gorbach of Clinical Infectious Diseases will discuss submission requirements that align with transfer of value reporting, writing for publication, and managing timelines.
With the Sunshine Act coming into fruition, the conference will have a heavy focus on the understanding of the transfer of value for Sunshine Act requirements, corporate integrity agreements, and creating industry-wide policies and best practices. Attendees will have the opportunity to discuss specific challenges faced with the new regulations, legal ramifications, and developing a cohesive and consistent interpretation of the Sunshine Act.
For more information or to register for the Pharmaceutical and Medical Device Scientific Communications Conference, please visit www.q1productions.com/scicomm. You can also follow Q1 Productions on Twitter @Q1Productions, #q1scicomm.
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.